ASCO 2020 (Virtual) May 29, 2020 Early_plasma_circulating_tumor_DNA_ctDNA_changes_to_predict_response_to_first-line_pembrolizumab_plus_chemotherapy_in_non-small_cell_lung_cancer.pdf
Early_plasma_circulating_tumor_DNA_ctDNA_changes_to_predict_response_to_first-line_pembrolizumab_plus_chemotherapy_in_non-small_cell_lung_cancer.pdf